11.13.23
During SupplySide West in Las Vegas, Kaneka Nutrients showcased the expanded use of Ubiquinol, an active metabolite of CoQ10, in reproductive health formulations.
A the event, Risa Schulman, PhD, the company’s scientific and regulatory advisor, showcased studies beyond those which investigated the role of the ingredient in heart health.
There’s growing evidence that oxidative stress is associated with premature aging and difficulty conceiving, Kaneka reports, and research demonstrates that the ingredient may be helpful during the preconception period.
Ubiquinol protects mitochondrial health and improves cellular energy production, which is necessary for both sperm motility and morphology, and oocyte quality and maturation. In clinical studies, Kaneka’s Ubiquinol has been shown to improve sperm motility by 31%, and increase sperm count by up to 62%.
"Ubiquinol is a naturally occurring form of CoQ10 in our bodies and an intrinsic part of our cellular machinery, especially vital in reproductive health. It's a potent antioxidant that shields both the sperm and ova from oxidative stress, a critical aspect given the rise in environmental and lifestyle challenges that can increase this stress,” said Schulman. "It's important to understand that as we age, and as we navigate through the challenges of modern life, our natural Ubiquinol levels can decline. This decline is associated with increased oxidative stress, which can potentially affect the quality of both sperm and ovum. For women 35 and older, it's particularly significant, impacting the ovarian reserve."
Schulman noted that Ubiquinol has enhanced absorption capabilities compared to traditional CoQ10, which needs to be converted by the body into ubiquinol.
“For brands considering integrating CoQ10 into their reproductive health supplements, switching to Kaneka Ubiquinol could be a pivotal move,” said Ron Martin, vice president.
“We’re excited to inform our brand holders, consumers, and healthcare providers about these breakthrough benefits,” said Jenn Fernandez, director of marketing.
A the event, Risa Schulman, PhD, the company’s scientific and regulatory advisor, showcased studies beyond those which investigated the role of the ingredient in heart health.
There’s growing evidence that oxidative stress is associated with premature aging and difficulty conceiving, Kaneka reports, and research demonstrates that the ingredient may be helpful during the preconception period.
Ubiquinol protects mitochondrial health and improves cellular energy production, which is necessary for both sperm motility and morphology, and oocyte quality and maturation. In clinical studies, Kaneka’s Ubiquinol has been shown to improve sperm motility by 31%, and increase sperm count by up to 62%.
"Ubiquinol is a naturally occurring form of CoQ10 in our bodies and an intrinsic part of our cellular machinery, especially vital in reproductive health. It's a potent antioxidant that shields both the sperm and ova from oxidative stress, a critical aspect given the rise in environmental and lifestyle challenges that can increase this stress,” said Schulman. "It's important to understand that as we age, and as we navigate through the challenges of modern life, our natural Ubiquinol levels can decline. This decline is associated with increased oxidative stress, which can potentially affect the quality of both sperm and ovum. For women 35 and older, it's particularly significant, impacting the ovarian reserve."
Schulman noted that Ubiquinol has enhanced absorption capabilities compared to traditional CoQ10, which needs to be converted by the body into ubiquinol.
“For brands considering integrating CoQ10 into their reproductive health supplements, switching to Kaneka Ubiquinol could be a pivotal move,” said Ron Martin, vice president.
“We’re excited to inform our brand holders, consumers, and healthcare providers about these breakthrough benefits,” said Jenn Fernandez, director of marketing.
